Journal of International Medical Research · 2013 · 79 citations · 30 references
MedicineGynecologyOncologyGynecologic OncologyMolecular OncologyMolecular PathologyCancer BiomarkersMicrorna BiologyNoncoding Rna In CancerOvarian CancerTumor MarkersMicrorna BiomarkersMicrorna In CancerMicrorna Prognostic MarkersMolecular Prognostic MarkersNoninvasive Diagnostic AssaysOvarian Cancer BiomarkersOvarian Cancer Prognostic BiomarkersPrognostic Marker Assessment
OBJECTIVE: To evaluate the feasibility of using serum microRNA (miR)-221 as a noninvasive diagnostic and prognostic biomarker in epithelial ovarian cancer (EOC). METHODS: In this retrospective study, real-time reverse transcription-polymerase chain reaction was used to measure miR-221 expression in serum samples from patients with EOC and healthy age-matched controls. Correlations between serum miR-221 levels and clinicopathological factors and prognosis were explored. RESULTS: Serum miR-221 was upregulated in patients with EOC (n = 96) compared with healthy controls (n = 35). The level of serum miR-221 expression was significantly associated with International Federation of Gynecology and Obstetrics stage, and tumour grade. Furthermore, multivariate analysis of overall survival showed that high serum miR-221 expression was an independent unfavourable prognostic factor in EOC. CONCLUSIONS: These findings indicate that serum miR-221 may have a role as a novel diagnostic and prognostic marker, and may have potential as a therapeutic target in EOC.
30
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman, Kyle Kai‐How Farh, Christopher B. Burge et al. · Genome Research · 2008 · 8.6K citations · Full text
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text
Real-time quantification of microRNAs by stem-loop RT-PCR
C. Chen · Nucleic Acids Research · 2005 · 5K citations · Full text
Xi Chen, Yi Ba, Lijia Ma et al. · Cell Research · 2008 · 4.6K citations